Dealmaking in Life Sciences and Healthcare: Trends and Developments

As part of The Dealmaker’s Edge: PE and M&A Perspectives – focused on developments and trends driving deals in the current market, our fifth installment features Milan Thakker, Corporate M&A partner in London, on Dealmaking in Life Sciences and Healthcare.

Milan discusses the current dealmaking environment in the life sciences and healthcare sector. He also shares his thoughts on and significant trends and challenges affecting life sciences and healthcare transactions, particularly in terms of deal volume, valuations, and competition for assets. He also shares the practical advice that he would offer to private equity investors and dealmakers working on deals within the life sciences sector.

As the M&A and private equity landscape evolves, staying informed is essential.